India’s COVID-19 Cases, Deaths Per Million Among Lowest In World: Centre

0
12
India's COVID-19 Cases, Deaths Per Million Among Lowest In World: Centre

New Delhi:

For every one million population, India’s coronavirus cases and fatalities are the lowest compared to the global average, the High Level Group of Ministers (GoM) reported on COVID-19 on Saturday.


The Health Ministry said that at the 20th meeting held in Delhi on Saturday, the GOM was briefed on COVID-19 about the current status of coronovirus outbreaks in India.

The meeting was told that as of Saturday, eight states – Maharashtra, Karnataka, Andhra Pradesh, Tamil Nadu, Uttar Pradesh, West Bengal, Odisha and Telangana – have contributed about 73 percent of the active Kasalod.

Seven states – Maharashtra, Delhi, Tamil Nadu, Andhra Pradesh, Karnataka, Uttar Pradesh and West Bengal – accounted for 81 percent of the total deaths due to coronovirus infection.

In the meeting, Union Health Minister Harsh Vardhan said that the country has made tremendous efforts in curbing the outbreak of COVID-19 and directed its ministry to provide standard operating procedures (SoPs) including COVID protocols and preventive measures for Parliament and Assembly sessions. To be developed.

GoM expressed concern about the upcoming festival season and advised everyone to adopt safe and COVID-appropriate behavior.

“Global comparisons have shown that India has the lowest deaths per million (2,424) and per million (44) deaths compared to the global average of 3,161 and 107.2 respectively,” the ministry said.

It underlined that despite the resource-constrained and dense population, timely lockdown and rapid growth of infrastructure has enabled India to reduce cases per million and death percentage significantly compared to other countries.

According to an official statement, Mr. Vardhan expressed satisfaction over the coordinated efforts of the Center, States and Union Territories.

“In the month since the last GoM meeting on July 31, we have made tremendous progress in tackling the disease. 26.4 lakh people have already recovered. The country’s fatal condition rate is at the lowest at 1.81 percent and steadily decreasing. He said that it has increased to 76.47 percent.

He further informed the GoM that with the creation of adequate health facilities, the health infrastructure in the country has been steadily strengthened.

The Health Minister said that apart from this, only 0.29 percent of the cases are on ventilator, 1.93 percent on ICU and only 2.88 percent of cases are on oxygen support.

“Currently a total of 1,576 laboratories have undergone testing and the target of 10 lakh tests per day has been met. More than nine lakh samples were tested in the last 24 hours and this has led to a cumulative figure of four crores. Crossing the figure, he said.

Mr. Vardhan informed the GoM that more than 338 lakh N-95 masks, about 135 lakh PPE and about 27,000 ventilators have been provided by the Center to the States and UTs.

NCDC Director Sujit Singh presented a detailed report on the surveillance efforts made in India during the epidemic through the Integrated Disease Surveillance Program (IDSP) network.

He mentioned that wearing masks, promoting physical disturbances and respiratory etiquette requires constant attention.

Chairman of Empowered Group-1 on Medical Emergency Management Plan, Dr. Vinod’s Paul briefed the Government of India about the process of COVID vaccine development in India and around the world.

He said 29 vaccine candidates, including two Indians, are in clinical trials. Of them, six are in three stages of testing.

In India, India is in a phase-two trial with Zydus Cadila, a biotech vaccine candidate based on inactivated viruses purchased by ICMR, based on viral DNA. The Oxford vaccine candidate is being put to the test by the Serum Institute of India, which is already in phase-three in Maharashtra and some other states.

Dr. Paul also informed GoM of the progress made by the National Expert Group on Vaccine Administration for COVID-19.

The group is facilitated by the development of vaccines, including trial and stockpiling, sorting financing issues, risk management, selecting potential beneficiaries and ordering them, visualizing logistics, scale-up, digital systems, beneficiary categories To select involves defining the principles. , And defines the scientific basis for the selection of the vaccine, the statement stated.

The National Expert Group has held three meetings so far.

Health Secretary Rajesh Bhushan apprised the GOM on the efforts made by the Ministry of Health towards addressing mental health during the epidemic. He said the center was in direct communication with the states, with states with an increase in cases and high mortality rates.

Shri Vardhan was joined by External Affairs Minister S. Jaishankar, Civil Aviation Minister Hardeep Singh Puri, Minister of State, Shipping (Independent Charge), Chemicals and Fertilizers Mansukh Lal Mandavia.